Punarnava Arka Standardization and clinical trial in Shushkakshipaka w.s.r.t.Dry Eye Syndrome
- Conditions
- Health Condition 1: H048- Other disorders of lacrimal system
- Registration Number
- CTRI/2024/04/065246
- Lead Sponsor
- KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur, BELAGAVI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Clinical features of DES with reduced quantity and stability of Tear Fluid
2 Age of 18 to 40 years and of either genders
Severe conditions like Steven Johnsons syndrome Chemical Thermal Radiation burns idiopathic atrophy Trachoma Ocular pemphigoid
Corneal epitheliopathies like Neuroparalytic keratitis post herpatic post measles infection of cornea
Conjunctival epitheliopathies like Pterygium Pseudo pterygium Tumours Retention cysts chronic low grade bacterial viral conjunctivitis
Lid abnormalities like Meibominitis Blepharitits Facial nerve palsy Lagophthalmous
Lacrimal gland diseases like infiltration of gland with sarcoidosis lymphoma leukemia and amyloidosis congenital Alacrima
Vitamin A deficiency effect of the drugs like atropine antihistamine diuretics
Specific systemic infections like Tuberculosis Leprosy Hypertension RA Diabetes mellitus etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of Punarnava Arka in dry eye syndromeTimepoint: Over a course of 45 days at the follow up period <br/ ><br>
- Secondary Outcome Measures
Name Time Method To improve the quality of life by reducing the symptomsTimepoint: Period of 45 days